Key result
Clinical risk factors including increasing age, systolic blood pressure, body mass index, and smoking history, but not glycaemic control, were the major independent determinants of stage B heart failure markers in asymptomatic adults with type 2 diabetes.
Why the study?
There is a high prevalence of asymptomatic stage B heart failure in people with type 2 diabetes, but clinical characteristics associated with its markers remain to be identified.
Cross-Sectional (n=247)
In asymptomatic adults with type 2 diabetes, modifiable risk factors like blood pressure and BMI, rather than glycemic control, are the major determinants of Stage B heart failure.
May warrant emphasis on BP and BMI management in asymptomatic T2D; leaves open causal role of glycemic control in Stage B HF.
BACKGROUND: There is a high prevalence of asymptomatic (American Heart Association Stage B) heart failure (SBHF) in people with type 2 diabetes (T2D). We aimed to identify associations between clinical characteristics and markers of SBHF in adults with T2D, which may allow therapeutic interventions prior to symptom onset. METHODS: = 247, age 52 ± 12 years, glycated haemoglobin A1c (HbA1c) 7.4 ± 1.1% (57 ± 12 mmol/mol), duration of diabetes 61 (32, 120) months] underwent echocardiography and adenosine stress perfusion cardiovascular magnetic resonance imaging. Multivariable linear regression analyses were performed to identify independent associations between clinical characteristics and markers of SBHF. RESULTS: In a series of multivariable linear regression models containing age, sex, ethnicity, smoking history, number of glucose-lowering agents, systolic blood pressure (BP) duration of diabetes, body mass index (BMI), HbA1c, serum creatinine, and low-density lipoprotein (LDL)-cholesterol, independent associations with: left ventricular mass:volume were age (β = 0.024), number of glucose-lowering agents (β = 0.022) and systolic BP (β = 0.027); global longitudinal strain were never smoking (β = -1.196), systolic BP (β = 0.328), and BMI (β = -0.348); myocardial perfusion reserve were age (β = -0.364) and male sex (β = 0.458); and aortic distensibility were age (β = -0.629) and systolic BP (β = -0.348). HbA1c was not independently associated with any marker of SBHF. CONCLUSIONS: In asymptomatic adults with T2D, age, systolic BP, BMI, and smoking history, but not glycaemic control, are the major determinants of SBHF. Given BP and BMI are modifiable, these may be important targets to reduce the development of symptomatic heart failure.
No takes yet. Share an insight, caveat, or question.
Brady et al. (2021) conducted a cross-sectional in Type 2 Diabetes and Stage B Heart Failure (n=247). Clinical risk factors (age, systolic blood pressure, BMI, smoking history) was evaluated on Markers of stage B heart failure (LV mass:volume, global longitudinal strain, myocardial perfusion reserve, aortic distensibility). Clinical risk factors including increasing age, systolic blood pressure, body mass index, and smoking history, but not glycaemic control, were the major independent determinants of stage B heart failure markers in asymptomatic adults with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: